PREVYMIS
- Product NDC
- 0006-5085
- 11-digit product format
- 000065085
- Labeler code
- 0006
- Product ID
- 0006-5085_282d792e-e2f2-4744-8526-4d18427c55cb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LETERMOVIR
- Dosage form
- PELLET
- Route
- ORAL
- Labeler
- Merck Sharp & Dohme LLC
- Application
- NDA219104
- Marketing category
- NDA
- Marketing start
- 2024-08-30
- Substance
- LETERMOVIR
- Active strength
- 120 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytomegalovirus DNA Terminase Complex Inhibitor [EPC], DNA Terminase Complex Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 1H09Y5WO1F | LETERMOVIR | 917389-32-3 | LETERMOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0006-5085-01 | 00006508501 | 30 PACKET in 1 CARTON (0006-5085-01) / 48 PELLET in 1 PACKET | 30 packet | 2024-08-30 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| PREVYMIS | Merck Sharp & Dohme LLC | 2026-01-14 | HUMAN PRESCRIPTION DRUG LABEL | 28 |